Stephen R. Bloom

ORCID: 0000-0003-1542-2348 · 6 papers in corpus
rct 2017
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dex253

STUDY QUESTION: Can increasing the duration of LH-exposure with a second dose of kisspeptin-54 improve oocyte maturation in women at high risk of ovarian hyperstimulation syndrome (OHSS)? SUMMARY ANSWER: A second dose of kisspeptin-54 at 1…

rct 2015
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2015-2332

CONTEXT: In vitro fertilization (IVF) treatment is an effective therapy for infertility, but can result in the potentially life-threatening complication, ovarian hyperstimulation syndrome (OHSS). OBJECTIVE: This study aimed to investigate …

nonrandomized-trial 2014
The Journal of clinical investigation ·doi:10.1172/jci75730

BACKGROUND: Patients with mutations that inactivate kisspeptin signaling are infertile. Kisspeptin-54, the major circulating isoform of kisspeptin in humans, potently stimulates reproductive hormone secretion in humans. Animal studies sugge…

rct 2000
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.85.7.6703

Pelvic endometriosis is an immune-related chronic inflammatory disease, characterized by ectopic implants of endometrium in the peritoneal cavity and associated with increased secretion of proinflammatory cytokines and neoangiogenesis. Lept…

case-report 1987
·doi:10.1080/01443615.1987.12088609

"Elevated plasma glucagon caused by danazol." Journal of Obstetrics and Gynaecology, 7(4), pp. 291–292

observational 1985
British medical journal (Clinical research ed.) ·doi:10.1136/bmj.291.6503.1155

The association between treatment with danazol and hyperglucagonaemia was studied. Plasma glucagon concentrations were measured during an oral glucose tolerance test in seven women taking danazol and six healthy controls not taking danazol.…